Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons
A series of potent and selective cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane (BCO) skeleton which have recently been described were found to show species-dependent behavior when examined in rat and dog models. W
Kalindjian, S. Barret,Buck, Ildiko M.,Davies, Jonathan M. R.,Dunstone, David J.,Hudson, Martin L.,Low, Caroline M. R.,McDonald, Iain M.,Pether, Michael J.,Steel, Katherine I. M.,Tozer, Matthew J.,Vinter
p. 1806 - 1815
(2007/10/03)
More Articles about upstream products of 1026556-36-4
Get Best Price for1026556-36-45-[(S)-2-({6-[(Adamantan-1-ylmethyl)-carbamoyl]-1H-indole-5-carbonyl}-amino)-3-(2-fluoro-phenyl)-propionylamino]-isophthalic acid dibenzyl ester